0
0 (0%)
Gbs Enterprises Inc [GBSX]
Source:
Company Overview
Marizymeis a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies thatimprove patient health outcomes.
| Country | United States |
| Headquarters | jupiter, florida |
| Phone Number | 561-935-9955 |
| Industry | manufacturing |
| CEO | David Barthel |
| Website | www.marizyme.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $-1.4 |
| Net Income | $-2 |
| Net Cash | $0 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -9.1% |
| Profit as % of Stockholder Equity | 12.6% |
Management Effectiveness
| Return on Equity | 12.6% |
| Return on Assets | -9.2% |
| Turnover Ratio | |
| EBITA | $-1.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $21.3 |
| Total Liabilities | $36.8 |
| Operating Cash Flow | $0 |
| Investing Cash Flow | |
| Financing Cash Flow | $0 |
